INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER

Datos básicos

Protocolo:
CB16/12/00484
EUDRACT:
NCT:
Centro:
Año de incio:
Año de finalización:
CIBER NACIONAL F.COMPETITIVA FIN. PUBLICA

Documentos

  • No hay documentos

Participantes

Grupos y Plataformas de I+D+i

Financiadores - Promotores

INSTITUTO SALUD CARLOS III

Resultados del Ensayo Clínico


11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.

Siaw, Joachim Tetteh; (...); Martinsson, Tommy

Article. 10.1016/j.celrep.2020.108171. 2020


Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines.

López-Carrasco, A; (...); Noguera, R

Article. 10.3390/cancers16193347. 2024

  • Open Access.

Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

Sanegre, S; (...); Noguera, R

Article. 10.3389/fcell.2021.670185. 2021


Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models.

Monferrer, Ezequiel; (...); Noguera, Rosa

Article. 10.3390/ijms21228676. 2020


Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

Stoks, M; (...); Noguera, R

Article. 10.1016/j.compbiomed.2023.107364. 2023


Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

Bellini, Angela; (...); Schleiermacher, Gudrun

Article. 10.1200/JCO.21.00086. 2021


High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.

Monferrer E; (...); Noguera R

Article. 10.1186/s12885-018-5219-3. 2019


Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.

Fernandez-Blanco, Beatriz; (...); Noguera, Rosa

Article. 10.1016/j.neo.2020.11.001. 2020


Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.

Sonzini, Giorgia; (...); Noguera, Rosa

Article. 10.3389/fcell.2022.1052098. 2022


Integrating the Tumor Microenvironment into Cancer Therapy.

Sanegre, Sabina; (...); Alvaro Naranjo, Tomas

Article. 10.3390/cancers12061677. 2020


Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.

Lopez-Carrasco, Amparo; (...); Noguera, Rosa

Article. 10.3390/cancers13205173. 2021


Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.

Monferrer, Ezequiel; (...); Alvaro Naranjo, Tomas

Article. 10.3390/metabo11050264. 2021


Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy.

Granados-Aparici, S; (...); Noguera, R

Article. 10.1016/j.isci.2024.111231. 2024

  • Open Access.

Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies

Benavent N; (...); Tadeo I

Article. 10.1002/pbc.31402. 2025

  • Open Access.

SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology Images.

Zormpas-Petridis, K; (...); Yuan, YY

Article. 10.3389/fonc.2020.586292. 2021


The complexity of cancer immunotherapy illustrated through skin tumors.

Vieco-Marti, I; (...); Alvaro Naranjo, T

Article. 10.1177/03936155221088884. 2022


The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection

Vicente-Munuera, P; (...); Escudero, LM

Article. 10.1002/ijc.32495. 2020


The tumour microenvironment as an integrated framework to understand cancer biology

Burgos-Panadero, R; (...); Noguera, R

Review. 10.1016/j.canlet.2019.07.010. 2019


Therapeutic Opportunities in Neuroblastoma Using Nanotechnology

Rodriguez-Nogales, C; (...); Blanco-Prieto, MJ

Review. 10.1124/jpet.118.255067. 2019


Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.

Burgos-Panadero, Rebeca; (...); Noguera, Rosa

Article. 10.1016/j.ijpharm.2021.121058. 2021

  • Open Access.

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma

Burgos-Panadero, R; (...); Noguera, R

Article. 10.1186/s12885-019-5693-2. 2019


Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

López-Carrasco A; (...); Noguera R

Article. 10.3390/ijms25168733. 2024

  • Open Access.

Compartir